Back
ProShares Short Dow30 Vs. Janux Therapeutics Industry Stock Comparison
Sell
35
DOG
ProShares Short Dow30
Last Price:
27.99
Seasonality Move:
-1.2%
Sell
44
JANX
Janux Therapeutics
Last Price:
44.05
Seasonality Move:
-18.02%
Sell
35
ProShares Short Dow30 (DOG)
is a Sell
Is ProShares Short Dow30 a Buy, Sell or Hold?
- The current ProShares Short Dow30 [DOG] share price is $28.43. The Score for DOG is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- DOG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $42.76. The Score for JANX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DOG Stock Price Chart
What is ProShares Short Dow30's stock price today?
-
The ProShares Short Dow30 share price today is $28.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DOG is experiencing buying pressure, which is a positive indicator for future bullish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $42.76
The current trend is moderately bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
DOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 47.65 | Sell |
| Chaikin Money Flow: | 1338158 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.1 - 29.02) | Sell |
| Bollinger Bands (100): | (28.51 - 29.57) | Sell |
JANX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 47.92 | Sell |
| Chaikin Money Flow: | -379974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.04 - 44.7) | Buy |
| Bollinger Bands (100): | (38.61 - 51.05) | Sell |
DOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.05 | Buy |
| 20-day SMA: | 28.42 | Buy |
| 50-day SMA: | 28.87 | Sell |
| 200-day SMA: | 30.02 | Sell |
| 8-day EMA: | 28.24 | Buy |
| 20-day EMA: | 28.42 | Buy |
| 50-day EMA: | 28.76 | Sell |
| 200-day EMA: | 29.89 | Sell |
JANX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.91 | Sell |
| 20-day SMA: | 42.68 | Buy |
| 50-day SMA: | 44.11 | Sell |
| 200-day SMA: | 27.77 | Buy |
| 8-day EMA: | 44.37 | Sell |
| 20-day EMA: | 43.63 | Sell |
| 50-day EMA: | 43.64 | Sell |
| 200-day EMA: | 32.85 | Buy |
ProShares Short Dow30 Earnings Growth & DOG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.06 per share, an increase this year of $0.11 per share, and a decrease next year of $0.39 per share.
ProShares Short Dow30 Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Janux Therapeutics Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||